Evidence map›Paper›PMID 30479066›Full record

ArticleBiotechnology progress2019

A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.

Sabrina Janoschek, Markus Schulze, Gerben Zijlstra, Gerhard Greller, Jens Matuszczyk

Abstract readComparative Study
In one paragraph

Article in Biotechnology progress, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Boosting Productivity for Advanced Biomanufacturing by Re-Using Viable Cells.Frontiers in bioengineering and biotechnology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sabrina JanoschekR&D BioProcessing, Sartorius Stedim Biotech GmbH, Göttingen, Germany.
Markus SchulzeR&D BioProcessing, Sartorius Stedim Biotech GmbH, Göttingen, Germany.
Gerben ZijlstraMab Segment Marketing, Sartorius Stedim Netherlands BV, Rotterdam, Netherlands.
Gerhard GrellerR&D BioProcessing, Sartorius Stedim Biotech GmbH, Göttingen, Germany.
Jens MatuszczykR&D BioProcessing, Sartorius Stedim Biotech GmbH, Göttingen, Germany.ORCID 0000-0001-6118-6679

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous processes such as perfusion processes can offer advantages compared to fed-batch or batch processes in bio-processing: improved product quality (e.g. for labile products), increased product yield, and cost savings. In this work, a semi-perfusion process was established in shake flasks and transferred to an automated small-scale bioreactor by daily media exchange via centrifugation based on an existing fed-batch process platform. At first the development of a suitable medium and feed composition, the glucose concentration required by the cells and the cell-specific perfusion rate were investigated in shake flasks as the conventional scale-down system. This lead to an optimized process with a threefold higher titer of 10 g/L monoclonal antibody compared to the standard fed-batch. To proof the suitability and benefit as a small-scale model, the established semi-perfusion process was transferred to an automated small-scale bioreactor with improved pH and dissolved oxygen control. The average specific productivity improved from 24.16 pg/(c*d) in the fed-batch process and 36.04 pg/c*d in the semi-perfusion shake flask to 38.88 pg/(c*d) in the semi-perfusion process performed in the controlled small-scale bioreactor, thus illustrating the benefits resulting from the applied semi-perfusion approach, especially in combination with controlled DO and pH settings. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 35: e2757, 2019.

Indexed as

AutomationBioreactorsPerfusionAnimalsCells, CulturedCHO CellsCricetulusHydrogen-Ion Concentrationcontinuous mammalian cell cultivationDoEmAbprocess optimizationsmall-scale bioreactor

Identifiers

PMID30479066
PMCPMC6667907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.